Weight-loss Journey

Our program prevents muscle and bone loss associated with using Ozempic, Mounjaro, and other GLP-1* agonists. Our Doctors of Physical Therapy offer tailored resistance training and nutritional guidance to protect your health and ensure sustainable, healthy results.

Ozempic Integrative Physical Therapy

Glucagon-like peptides (GLP-1 drugs)* such as Ozempic and Mounjaro are proving to be breakthroughs in weight management. Yet, these advancements are not without challenges, including significant impacts on muscle mass and bone density, which heighten injury risk and contribute to conditions like osteoporosis. While the notion of a “magic injection” is appealing, combining it with expert nutritional, health, and musculoskeletal guidance from our Doctors of Physical Therapy ensures safe and sustainable results.

Our professionals excel in offering customized programs to protect your musculoskeletal health. As you achieve your weight loss objectives, we’ll empower you to confidently engage in new activities using your transformed physique, leading you to healthy and lasting results.

*Our programs support patients who are utilizing the following GLP-1 peptide agonists. Byetta, Dulaglutide, Exenatide, Exenatide extended-release, Liraglutide, Lixisenatide, Mounjaro, Ozempic, Saxenda, Semaglutide, Rybelsus, Trulicity, Victoza, Wegovy, Zepbound

arnold's pump club
album-art

00:00
Our website is undergoing maintenance and you may not be able to reach us via our emailus@njcpt.com address. 
To connect with us, please call us at (973) 248-8111 or email us at emailus@wayneorthopt.com

Team Awards

Columbia University icon Designated Site of Clinical Excellence

Columbia University

Designated Site of Clinical Excellence

NJCPT logos for medicine

Rutgers School of Health Related Professions

Alumni Award Winner

Montclair State University award

Montclair State University

Sports Medicine Center named in our Founder's Honor

Hospital for Special Surgery

Hospital For Special Surgery

Provider Certification